You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neovascular Membrane

Showing 1 - 25 of 2,497
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Optical Coherence Tomography Angiography Criteria Of The

Not yet recruiting
  • Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
  • Optical coherence tomography angiography
  • (no location specified)
Sep 27, 2022

OCTA Insights in CNVM, Morphological Characteristics and

Not yet recruiting
  • Choroidal Neovascularization
    • (no location specified)
    Sep 14, 2021

    Anti-VEGF in Real-world

    Recruiting
    • Neovascular Age-related Macular Edema
    • +5 more
    • Beijing, Beijing, China
      Wen-Bin Wei
    Feb 2, 2022

    Wet Macular Degeneration Trial in Los Angeles (Aflibercept Ophthalmic, optovue angiovue)

    Completed
    Has Results
    • Wet Macular Degeneration
    • Aflibercept Ophthalmic
    • optovue angiovue
    • Los Angeles, California
      Stein Eye Institute of UCLA
    Dec 9, 2021

    Tumors Trial in Beijing ([68Ga]P3)

    Recruiting
    • Neoplasms
    • Beijing, Beijing, China
      Peking University First Hospital
    Jul 4, 2023

    Tumors Trial in Beijing ([68Ga]P3)

    Recruiting
    • Neoplasms
    • Beijing, Beijing, China
      Peking University First Hospital
    Jun 4, 2023

    Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Phoenix, Arizona
      Retinal Research Institute, LLC
    Jun 4, 2023

    Neovascular Age-Related Macular Degeneration Trial in Worldwide (Ranibizumab, Aflibercept, Port Delivery System with ranibizumab

    Suspended
    • Neovascular Age-Related Macular Degeneration
    • Capital Federal, Argentina
    • +9 more
    Nov 8, 2022

    Neovascular Age-related Macular Degeneration Trial (dose 1 IBI302, Aflibercept, dose 2 IBI302)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • dose 1 IBI302
    • +2 more
    • (no location specified)
    May 26, 2022

    Photobiomodulation, Age-Related Macular Degeneration Trial (Valeda machine)

    Not yet recruiting
    • Photobiomodulation
    • Age-Related Macular Degeneration
    • Valeda machine
    • (no location specified)
    Aug 22, 2022

    Defining Disease Activity in Neovascular AMD With Optical

    Recruiting
    • Neovascular Age-related Macular Degeneration
      • London, United Kingdom
        Moorfields Eye Hospital NHS Foundation Trust, 162 City Road
      Aug 19, 2021

      Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)

      Recruiting
      • Exudative Macular Degeneration
      • Wet Age-related Macular Degeneration
      • Doxycycline Hyclate
      • Placebo
      • Iowa City, Iowa
        University of Iowa Hospitals & Clinics Department of Ophthalmolo
      Apr 5, 2022

      Neovascular Age-related Macular Degeneration Trial in Phoenix, Winter Haven, Cleveland (Placebo, LFG316)

      Terminated
      • Neovascular Age-related Macular Degeneration
      • Phoenix, Arizona
      • +2 more
      Dec 11, 2020

      OCT Angiography in Wet AMD

      Recruiting
      • Neovascular (Wet) Age-related Macular Degeneration (AMD)
      • Optical Coherence Tomography
      • Portland, Oregon
        Casey Eye Institute, Oregon Health & Science University
      Sep 20, 2022

      Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)

      Completed
      Has Results
      • Wet Macular Degeneration
      • Phoenix, Arizona
      • +138 more
      Dec 16, 2022

      Vogt Koyanagi Harada Disease Trial in São Paulo (Early high-dose corticosteroid and immunosuppressive therapy)

      Recruiting
      • Vogt Koyanagi Harada Disease
      • Early high-dose corticosteroid and immunosuppressive therapy
      • São Paulo, SP, Brazil
        Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidad
      Jan 4, 2022

      OCT Biomarkers for Diabetic Retinopathy

      Active, not recruiting
      • Diabetic Retinopathy
        • Portland, Oregon
          Oregon Health & Science University
        Jul 13, 2021

        Number of Patient Eyes That Remained on or Switched to Anti-VEGF

        Completed
        • Age-related Macular Degeneration (AMD)
        • East Hanover, New Jersey
          Novartis Investigational site
        Oct 6, 2021

        Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)

        Completed
        Has Results
        • Wet Macular Degeneration
        • Mesa, Arizona
        • +159 more
        Apr 6, 2022

        Glioma Trial in Beijing (68Ga-P16-093)

        Recruiting
        • Glioma
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Oct 4, 2022

        Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion With Macular Edema Trial in Makati

        Completed
        • Neovascular Age-related Macular Degeneration
        • +4 more
        • Intravitreal injection guide (Malosa)
        • Dual Blade Eyelid Speculum
        • Makati City, MM, Philippines
          Peregrine Eye and Laser Instittute
        Apr 25, 2021

        Neovascular Age-related Macular Degeneration Trial in Seongnam-si (Probiotic Combination Cap/Tab, intravitreal Anti-VEGF

        Recruiting
        • Neovascular Age-related Macular Degeneration
        • Probiotic Combination Cap/Tab
        • intravitreal Anti-VEGF injection
        • Seongnam-si, Korea, Republic of
          Seoul National University Bundang Hospital
        Nov 1, 2022

        Neovascular Age-related Macular Degeneration Trial in United States (OLX10212 is a cell penetrating asymmetric small

        Recruiting
        • Neovascular Age-related Macular Degeneration
        • OLX10212 is a cell penetrating asymmetric small interference RNA (cp-asiRNA)
        • Santa Maria, California
        • +4 more
        Jan 10, 2023

        Neovascular Age-related Macular Degeneration Trial in Italy (Brolucizumab)

        Recruiting
        • Neovascular Age-related Macular Degeneration
        • Ancona, AN, Italy
        • +18 more
        Aug 10, 2022

        Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,

        Not yet recruiting
        • Neovascular Age-related Macular Degeneration
        • Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
        • Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
        • (no location specified)
        Jun 6, 2023